Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sapient Capital Management is a private venture capital and investment management firm focused on healthcare-related businesses, particularly medical device companies addressing unmet medical needs. The firm has been described as investing primarily in seed, start-up, and early-stage healthcare companies, while also considering select small-cap public healthcare investments. Its emphasis appears to be on backing entrepreneurs building novel device-based solutions rather than operating its own therapeutic pipeline. Sapient Capital Management is associated with founder and principal Mitchell Dann and has been based in Wilson, Wyoming. It should be classified as a healthcare-focused investment firm rather than a biotech, pharma, or therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sapient Capital Management.